Ϫ -dependent manners. Although the transport substrates and physiological relevance of the majority of the members have already been determined, little is known about SLC17A4 proteins known to be Na ϩ -phosphate cotransporter homologue (NPT homologue). In the present study, we investigated the expression and transport properties of human SLC17A4 protein. Using specific antibodies, we found that a human NPT homologue is specifically expressed and present in the intestinal brush border membrane. Proteoliposomes containing the purified protein took up radiolabeled p-aminohippuric acid (PAH) in a Cl Ϫ -dependent manner at the expense of an electrochemical gradient of protons, especially ⌬, across the membrane. The ⌬-and Cl Ϫ -dependent PAH uptake was inhibited by diisothiocyanostilbene-2,2=-disulfonic acid and Evans blue, common inhibitors of SLC17 family members. cis-Inhibition studies revealed that various anionic compounds, such as hydrophilic nonsteroidal anti-inflammatory drugs, pravastatin, and urate inhibited the PAH uptake. Proteoliposomes took up radiolabeled urate, with the uptake having properties similar to those of PAH uptake. These results strongly suggested that the human NPT homologue acts as a polyspecific organic anion exporter in the intestines. Since SLC17A1 protein (NPT1) and SLC17A3 protein (NPT4) are responsible for renal urate extrusion, our results reveal the possible involvement of a NPT homologue in urate extrusion from the intestinal duct. Na ϩ -phosphate cotransporter homologue; organic anion transporter; urate; intestine; chloride ion THE EXCRETION OF METABOLIC waste compounds and xenobiotics is an essential step for maintaining homeostasis. This excretion occurs transcellularly across epithelial cells through two distinct transport systems. In the kidneys, organic cation transporter 2 (OCT2, SLC22A2) takes up various organic cations at the basolateral membrane of urinary tubules, which is then excreted at the luminal membrane through multidrug resistance protein 1 (MDR1, ABCB1), multidrug and toxic compound extrusion 1 (MATE1, SLC47A1), and MATE2 (SLC47A2) (7, 11, 13, 21, 23, 24, 36) . In the case of organic anions, organic anion transporter 1 (OAT1, SLC22A6) and OAT3 (SLC22A8) take up various organic anions at the basolateral membrane through the exchange of intracellular dicarboxylates, such as ␣-ketoglutarate, which is excreted at the apical membrane through multidrug resistanceassociated protein 2 (MRP2, ABCC2), MRP4 (ABCC4), breast cancer resistance protein (BCRP, ABCG2), and SLC17A1 protein [Na ϩ -phosphate cotransporter 1 (NPT1)]-mediated transport (6, 7, 11, 24, 36) . Thus the combination of ATP binding cassette (ABC)-type transporters and solute carrier (SLC)-type transporters is important for the extrusion of metabolic waste products and xenobiotics.
The small intestine represents the primary site of absorption for all ingested compounds. Nutrients and solutes in the intestinal lumen are taken up at the brush border membrane, followed by intracellular transport across the cytosol, and then exiting at the basolateral membrane into the blood. Likewise, metabolic waste products and xenobiotics taken up from the intestinal lumen or blood may be extruded back into the intestinal lumen (3, 32) . Although previous reports suggested the participation of ABC transporters, such as MDR1, MRP2, and BCRP, as ATP-driven efflux transporters in the extrusion process (3, 32) , little is known about the overall features and molecular mechanism of extrusion in the intestines. In particular, it remains unknown whether or not a SLC-type transporter(s) participates in the extrusion process, and, if so, which type of transporter is responsible for the process.
The SLC17 family comprises nine members and represents OATs in humans (see Fig. 1A ). SLC17A1 (NPT1) and SLC17A3 (NPT4) present in the luminal membrane of renal urinary tubules and act as membrane potential (⌬-and Cl Ϫ -dependent polyspecific organic anion exporters of urate and other anionic drugs) (6, 10) . SLC17A5 protein is localized to lysosomes and synaptic vesicles and is responsible for sialic acid extrusion from lysosomes and aspartate storage in synaptic vesicles of aspartergic neurons (18, 19) . SLC17A6, A7, and A8 encode vesicular glutamate transporters (VGLUTs), which are localized to synaptic vesicles and secretory granules and are responsible for the vesicular storage of L-glutamate, an essential step in glutamatergic chemical transmission (25) . SLC17A9 protein is the last member and is responsible for the vesicular storage of nucleotides, such as ATP, and is involved in purinergic chemical transmission (15, 20, 27) . Biochemical studies involving the purified protein demonstrated that these members share common transport properties: essential amino acid residues, inhibitors, driving force, Cl Ϫ dependence, and ketone body reversible inhibition, leading to the conclusion that this family acts as ⌬-and Cl Ϫ -dependent OATs (8) . SLC17A4 (NPT homologue) belongs to the NPT subfamily, and its mRNA was shown to be expressed predominantly in the pancreas, liver, colon, and small intestine (25, 29) , although no function as a transporter has been assigned so far. Since other NPT subfamily transporters were not expressed in intestine (10, 25, 35) , we hypothesized that the NPT homologue is an intestinal organic anion exporter. In the present study, we investigated this possibility, finding that this protein actually exists in the apical membrane of the small intestine and transports various kinds of organic anions, including urate, in ⌬-and Cl Ϫ -dependent manners.
MATERIALS AND METHODS
cDNA. cDNA of human SLC17A4 (accession no. NM005495) was cloned by PCR.
Real-time PCR. Human total RNAs from several tissues were purchased from Clontech. cDNA was generated from total RNA with a Reverse Transcriptase Kit (Toyobo) using 1 g of total RNA as the template. The resulting cDNA pool was used for real-time PCR. Realtime PCR was carried out with 400 nmol/l of specific forward and reverse primers, respectively, and 5 U/l of SYBR Premix Ex Taq (TaKaRa). Reactions were performed 35 times with denaturation at 95°C for 15 s, and annealing/extension at 60°C for 30 s. The primer set used for detection of human NPT (hNPT) homologue was as follows: 5=-ctccactgactcccagggct-3=, 5=-ctggggattggagccaagaatgag-3=. The expression of hNPT homologue was evaluated relative to the mRNA expression of the housekeeping gene, glyceraldehyde 3-phosphate dehydrogenase.
Antibodies. Site-specific rabbit polyclonal antibodies against hNPT homologue were prepared by repeated injection of glutathi- one S-transferase fusion polypeptides encoding amino acid residues M1-K30 of hNPT homologue (MSTGPDVKATVGDISS-DGNLNVAQEECSRK). Site-specific rabbit polyclonal antibodies against mouse NPT homologue (mNPT homologue) were prepared by repeated injection of glutathione S-transferase fusion polypeptides encoding amino acid residues M1-C30 of mNPT homologue (MSTGADLKAREGDIPSDNMTQEQSFKKGFC).
Immunohistochemistry. Paraffin sections of human tissues were obtained from Biochain. Mouse tissue sections were prepared from male ddY mice (8 wk old, 35 g). All animal procedures and care were approved by the Institutional Animal Care and Use Committee and were carried out according to the guidelines of Okayama University. Immunohistochemical analysis was performed by the horseradish peroxidase-3,3=-diaminobenzidine (DAB) method or indirect immunofluorescence microscopy, as described previously (5, 23). The horseradish peroxidase-DAB method was performed as follows: in brief, specimens were incubated for 30 min in phosphate-buffered saline (PBS) containing 1.5% goat serum. The specimens were then incubated with anti-hNPT homologue antibodies diluted to 200-fold with PBS containing 0.1% BSA and 0.05% Tween 20 for 1 h at room temperature. Samples were washed four times with PBS containing 0.05% Tween 20, and then reacted with biotinylated-labeled antirabbit IgG (7 g/ml) as the secondary antibodies for 30 min at room temperature. Samples were washed four times with PBS containing 0.05% Tween 20, reacted with VECTASTAIN ABC reagent (Vector) for 30 min, and then incubated with a peroxidase substrate solution comprising 0.02% DAB and 0.005% H 2O2. Finally, immunoreactivity was examined under a microscope. Indirect immunofluorescence microscopy was also performed as follows: in brief, specimens were incubated for 30 min in the same buffer as above containing 0.1% (5 g), were electrophoresed on a 10% polyacrylamide gel and visualized by Coomassie brilliant blue staining. In a parallel experiment, these proteins were transferred to a nitrocellulose sheet, and then Western blot analysis with anti-hNPT holomogue antibodies was conducted. Asterisks indicate each expressed transporter. Arrowheads indicate immunoreactive signals originated from E. coli membrane, but not expressed transporters. B, left: horseradish peroxidase-3,3=-diaminobenzidine immunostaining and indirect immunofluorescence microscopy revealed that hNPT homologue was localized in the small intestine. Arrows indicate hNPT homologuepositive signals. Right: no immunoreactivity was observed in the control, which was conducted with IgG instead of hNPT homologue antibodies. Bottom: hNPT homologue was not detected in the liver, kidneys, or pancreas on indirect immunofluorescence microscopy. Scale bar ϭ 10 m.
Triton X-100, followed by PBS containing 2% goat serum and 0.5% BSA. The specimens were then incubated with anti-hNPT homologue antibodies or anti-mNPT homologue antibodies diluted to 200-fold with PBS containing 0.5% BSA for 1 h at room temperature. Samples were washed four times with PBS and then reacted with Alexa Fluor 488-labeled anti-rabbit IgG (2 g/ml) as the secondary antibodies for 1 h at room temperature. Finally, immunoreactivity was examined under an Olympus BX60 microscope.
Preparation of intestinal membrane fractions. Small intestines were isolated from ddY mice (8 wk old, 35 g). After washing with 10 mM MOPS-Tris, pH 7.0, containing 300 mM sucrose, 5 mM EDTA, 10 g/ml pepstatin A, and 10 g/ml leupeptin, the whole intestine was dissected with scissors and homogenized with a homogenizer in the same buffer and then centrifuged at 12,000 g at 4°C for 10 min to remove organelles and cell debris. The resultant supernatant was carefully taken and centrifuged again at 150,000 g for 1 h at 4°C. The pellet (whole intestine membrane fraction) was suspended with the same buffer. The luminal surface of intestines was scraped with a slide glass and homogenized with a homogenizer in the same buffer. The membrane fraction of the luminal surface homogenate was prepared by centrifugation and suspended with the same buffer as above.
Expression and purification of hNPT homologue. E. coli C43 (DE3) cells were transformed with expression vectors and grown in TB medium containing 20 g/ml kanamycin sulfate at 37°C (16) . E. coli cells were grown until absorbance at 600 nm reached 0.6 -0.8, and then isopropyl-␤-D-thiogalactopyranoside was added to give a final concentration of 1 mM, and the culture was further incubated for 16 h at 18°C. Then the cells were harvested by centrifugation and suspended in buffer comprising 20 mM Tris·HCl, pH 7.5, 100 mM NaCl, 10 mM KCl, and 2 mM phenylmethylsulfonyl fluoride. The cell suspension was then disrupted by sonication with a TOMY UD200 tip sonifier (OUTPUT4), and centrifuged at 5,856 g at 4°C for 10 min to remove large inclusion bodies and cell debris. The resultant supernatant was carefully taken and centrifuged again at 150,000 g for 1 h at 4°C. The pellet was suspended in the same buffer, and the protein concentration was adjusted to 10 mg/ml. Then the membranes were treated with 1.5% Fos-choline 14 (Affymetrix), and centrifuged at 150,000 g at 4°C for 1 h. The supernatant containing the hNPT homologue was taken, diluted twice with buffer comprising 20 mM Tris·HCl, pH 7.5, 100 mM NaCl, 10 mM KCl, and 2 mM phenylmethylsulfonyl fluoride, and then applied to a column containing 1 ml of nickel-NTA Superflow resin (Qiagen) equilibrated with buffer comprising 20 mM Tris·HCl, pH 8.0, 100 mM NaCl, and 10 mM KCl. After incubation for 1 h at 4°C, the column was washed with washing buffer comprising 20 mM Tris·HCl, pH 8.0, 20 mM imidazole, 100 mM NaCl, 10 mM KCl, and 1% octylglucoside (Dojindo). The hNPT homologue protein was eluted with buffer comprising 20 mM Tris·HCl, pH 8.0, 300 mM imidazole, 100 mM NaCl, 10 mM KCl, and 1% octylglucoside, and then stored at Ϫ80°C, at which it was stable without loss of activity for at least a few months.
Reconstitution. Reconstitution of the purified hNPT homologue into liposomes was carried out by the freeze-thaw method described previously (8, 9) . In brief, 30 g hNPT homologue and 90 g bacterial F-ATPase were mixed with liposomes (0.5 mg lipid), frozen at Ϫ80°C, and then left at this temperature for at least 10 min. The mixture was thawed quickly by holding the sample tube in the hands and then diluted 20-fold with reconstitution buffer comprising 20 mM MOPS-Tris, pH 7.0, 100 mM potassium acetate, 5 mM magnesium acetate, and 0.5 mM dithiothreitol. Proteoliposomes were sedimented by centrifugation at 200,000 g for 1 h at 4°C and suspended in 0.4 ml of reconstitution buffer.
Transport assay. Proteoliposomes (1.5 g total protein/assay) were suspended in 20 mM MOPS-Tris, pH 7.0, 5 mM magnesium acetate, 4 mM KCl, and 100 mM potassium acetate, and then incubated for 3 min at 27°C. ATP was added to give a final concentration of 2 mM, and the mixture was incubated for a further 2 min. The assay was initiated by the addition of 100 M p-[glycyl- 2- 3 H]p-aminohippuric acid (PAH) (0.6 MBq/mol); 130 l aliquots were taken at the times indicated and centrifuged through a Sephadex G-50 (fine) spin column at 760 g for 2 min. Radioactivity in the eluate was measured with a liquid scintillation counter. Valinomycin-induced PAH or urate uptake was measured as described (6) . All numerical values show means Ϯ SE; n ϭ 3-5.
Miscellaneous procedures. The transporters used in Fig. 2 were purified according to published procedures (8, 16) . F-ATPase and asolectin liposomes were purified from E. coli as described previously (22) . Polyacrylamide gel electrophoresis in the presence of SDS and Western blotting were performed as described (22) . Protein concentrations were determined using BSA as a standard (28) .
RESULTS
Localization of NPT homologue in the small intestine. As the first step of the study, we measured the degree of expression of the hNPT homologue gene by real-time PCR analysis (Fig.  1B) . hNPT homologue signal exhibited a single band with a single melting temperature value, indicating that the signal represents only hNPT homologue gene (Fig. 1, C and D) . Consistent with the previous observation (29), the hNPT homologue gene was abundantly expressed in the pancreas, liver, colon, and small intestine, in that order, and less so in the kidneys, while no expression or expression under the detection limit was observed in the adrenal glands, brain, placenta, heart, testes, skeletal muscle, and lungs, confirming expression of hNPT homologue in intestines (Fig. 1, B-D) .
Subsequently, we prepared a specific polyclonal antibody against hNPT homologue to determine the expression and localization of NPT homologue. To test the immunological specificity, the hNPT homologue protein was overexpressed in E. coli, solubilized, and then purified by affinity column chromatography. The degree of purification was confirmed by SDS polyacrylamide gel electrophoresis, followed by staining with Coomassie brilliant blue. The purified hNPT homologue corresponded to a polypeptide of 72 kDa, which is the expected size due to YbeL (120 amino acids) conjugate at both NH 2 -and COOH-terminus ( Fig. 2A) (16) . Other SLC17 members were also partially purified, according to the published procedures, and the immunological reactivity of the antibodies to these proteins was compared. As shown in Fig. 2A (asterisks) , the polyclonal antibody could detect hNPT homologue protein, but did not detect NPT1, NPT3, NPT4, vesicular excitatory amino acid transporter (SLC17A5 gene product), and vesicular nucleotide transporter (SLC17A9 gene product). A slight immunoreaction (Ͻ10%) with VGLUT was observed. It should be stressed that the antibodies also recognized a protein band with apparent molecular mass of 68 kDa in the fractions containing NPT3, NPT4, and vesicular excitatory amino acid transporter, which was originated from E. coli membranes expressing these transporters ( Fig. 2A, arrowheads) . These results indicate the immunological specificity of the antibodies for hNPT homologue.
We then looked for the localization of hNPT homologue by immunohistochemical analysis (Fig. 2B) . We found that the antibody reacted with epithelial cells of the intestinal villi (Fig.  2B, left) , while control IgG did not react in the serial section (Fig. 2B, right) . In contrast to the abundant expression of the mRNA in the liver and pancreas, however, the immunological reactivity of hNPT homologue was not detected in these tissues and kidneys, suggesting that hNPT homologue protein was not present in these tissues or under the detection limit in our assay (Fig. 2B, bottom panels) . From these observations, it is concluded that hNPT homologue is expressed and present at brush border membrane of the intestines.
To strengthen the above conclusion further, we examined the expression and localization of the NPT homologue protein in the intestines of mice. Using specific antibodies against mNPT homologue, we detected three major polypeptides with apparent molecular masses of 70, 54, and 50 kDa in the membrane fraction of luminal surface of intestines upon immunoblotting, while the density these polypeptides was significantly lower in the membrane from whole intestines (Fig. 3A) . Consistently, mNPT homologue was localized at apical membrane in the small intestine (Fig. 3B) .
Functional characterization of hNPT homologue. To examine the transport properties of hNPT homologue, the purified hNPT homologue protein was reconstituted with bacterial F-ATPase into asolectin liposomes by freezing/thaw/dilution, according to a previously published procedure (9, 22) . This assay system enables one to examine the secondary active transport driven by an electrochemical gradient of protons across a membrane upon the addition of ATP, since F-ATPase is an electrogenic proton pump, and thus change (⌬) in pH and ⌬ is established across the membrane due to proton entry through F-ATPase (9, 22) . In fact, upon the addition of ATP, the proteoliposomes actively took up radiolabeled PAH (Fig. 4A) . In the absence of ATP, the PAH uptake was significantly reduced, corresponding to passive transport. Only backgroundlevel uptake was observed for liposomes lacking hNPT homologue (Fig. 4A) . Under the used conditions, the addition of valinomycin in the presence of K ϩ abolished ⌬, but not ⌬pH, and reduced PAH uptake (Fig. 4B) . In contrast, nigericin abolished the ⌬pH, but not the ⌬, and did not have any significant effect on PAH (Fig. 4B) . These results suggested that the uptake of PAH is preferentially driven by ⌬, but not ⌬pH.
To confirm ⌬ is a direct driving force for PAH uptake further, proteoliposomes were assayed by the valinomycininduced method (8) . The addition of valinomycin in the presence of external K ϩ generated a K ϩ diffusion potential (around Ϫ90 mV positive inside) across the liposomal membrane (8) and thereby facilitated PAH uptake (Fig. 4C) . In the absence of valinomycin, the PAH uptake was significantly reduced. The addition of nigericin in the presence of K ϩ established ⌬pH (outside acidic) but not ⌬, and thus did not drive PAH uptake (Fig. 4C) .
Kinetic analysis of ATP-dependent PAH uptake showed K m and V max values of 0.7 mM and 74.6 nmol·min Ϫ1 ·mg protein
Ϫ1
, respectively (Fig. 4D) . PAH transport obligatorily required Cl Ϫ and was inhibited by DIDS and Evans blue (Fig. 4,  E and F) . As shown in Table 1 , cis-inhibition studies indicated that the PAH uptake was sensitive to aspirin, salicylate, ibuprofen, pravastatin, and urate, suggesting strongly that NPT homologue recognizes these compounds as transport substrates. In contrast, hNPT homologue did not recognize tetraethylammonium, a typical substrate of OCTs, indicating that its substrate specificity is different from those of cation transporters such as OCT or MATE. Essentially the same transport properties were observed for the mNPT homologue (data not shown).
It is known that members of the SLC17 family transport inorganic phosphate (P i ) upon the imposition of a Na ϩ gradient (6, 9, 25) . We thus examined whether or not hNPT homologue also possesses such activity. As we expected, hNPT homologue took up P i , depending on Na ϩ (Fig. 5 ). In the absence of Na ϩ , the P i uptake was significantly reduced. The Na ϩ -dependent P i uptake was insensitive to DIDS and Evans blue and independent of ⌬ and Cl Ϫ (data not shown), with these properties being consistent with those of Na ϩ -dependent P i uptake by NPT1 and VGLUT2 (6, 9) .
hNPT homologue is a urate exporter. The cis-inhibition shown in the previous section suggested that urate is a substrate for hNPT homologue. We thus investigated whether or not hNPT homologue actually takes up radiolabeled urate. As shown in Fig. 6A , hNPT homologue transported urate in a 6B) . The ⌬-dependent urate uptake activity required Cl Ϫ and was inhibited by a low concentration of DIDS (Fig. 6, C and  D) . These transport properties are similar to those of PAH uptake by hNPT homologue, indicating that it is a urate transporter.
DISCUSSION
In the present study, we investigated the localization and transport properties of NPT homologue and found that it is actually present at the intestinal brush border membrane. Although mRNA of hNPT homologue is abundant in the liver and pancreas, we did not detect hNPT homologue protein on immunohistochemistry, suggesting strongly that no or very low amounts of the hNPT homologue protein are present in these organs. The reason for the mRNA and protein imbalance is unknown at present. However, it should be stressed that this is not a specific case for NPT homologue, and similar phenomena have been observed for other SLC17 members (2, 4, 27) . Subsequently, using proteoliposomes containing the purified protein, we demonstrated that hNPT homologue transports PAH at expense of ⌬ but not ⌬pH. The transport required a low concentration of Cl Ϫ and was inhibited by typical inhibitors of the SLC17 family. cis-Inhibition studies suggested that NPT homologue recognizes hydrophilic anionic drugs such as aspirin, salicylate, and ibuprofen as substrates. Thus these results demonstrated that NPT homologue is a polyspecific anion exporter. Taking the localization and driving force into consideration, it is quite probable that hNPT homologue is involved in the extrusion of various kinds of organic anions in the intestines.
Tetracycline transporter-like protein (TETRAN) and NPT1 are known to be nonsteroidal anti-inflammatory drugs (NSAIDs) exporters in the kidneys (6, 33) . TETRAN recognizes hydrophobic NSAIDs, such as indomethacin and etodolac and mefenamic acid as transport substrates, while NPT1 recognizes hydrophilic NSAIDs, such as aspirin and salicylate (6, 33) . Since TETRAN is also expressed in the small intestine (33) , it is possible that functional coordination of NPT homologue and TETRAN may be necessary to extrude NSAIDs in the intestines. In this respect, it is noteworthy that MATE1, a polyspecific drug exporter of a wide variety of cationic drugs that coordinately functions with MDR1 in the kidneys and liver, is also present in the intestinal brush border membrane (M. Hiasa and Y. Moriyama, unpublished observation).
It should be stressed that urate is a good substrate for hNPT homologue, suggesting that hNPT homologue exports urate under physiological conditions. Urate is the end product of purine metabolism in humans and acts as a natural antioxidant with neuroprotective properties (14) . Elevated serum urate levels caused by the loss of urate oxidase activity may have provided a survival advantage, because hyperuricemia helped to maintain blood pressure levels under the low-salt dietary conditions that prevailed in the middle to late Miocene (34) . It is also known that an elevated serum urate level is also quite disadvantageous for life, because it is associated with several metabolic disorders, such as gout and kidney stones in humans (1) . Urinary extrusion of urate is predominant and accounts for two-thirds of total elimination (30, 31) . Although the remaining urate is excreted from the intestines, the mechanism of extrarenal extrusion is poorly understood. The present study suggests the possibility that the intestines are the site of extraurate excretion. Since BCRP, which is involved in the urinary excretion of urate, also express in the intestines (3, 17) , it is possible that a similar, but not an identical, transcellular excretion mechanism operates in the intestines. It is also noteworthy that recent meta-analysis revealed that an additional locus on chromosome 6p23-p21.3 encompassing three members of the SLC family 17 (SLC17A1, SLC17A3, and SLC17A4) is associated with the serum urate level (12, 26) .
In conclusion, we present evidence that NPT homologue is an intestinal organic anion exporter that acts in ⌬-and Cl Ϫ -dependent manners. It is proposed that the intestines are the site of extraurate or drug excretion.
